Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail
-

Docket Management Process - Considerations

View PDF of the Docket Management Process Section (31 KB)

Background

Summary of Public Comments

Transparency Report Arrow Considerations

View All Docket Management Draft Proposals   

 

Considerations

The Task Force considered whether FDA should post online all of the comments submitted to an Agency docket.  The Task Force also considered the rationale for treating comments from individual consumers differently, in terms of whether they are posted online, from comments submitted by other members of the public.

 

The Task Force also considered the interest in not providing personal information about the commenter, such as the person’s name or address, on a public Web site.  The Task Force recognizes that public availability of this information may be more of a concern when a person is sending comments as an individual, as opposed to on behalf of an organization, business, or other entity.

-
-